This is why Bayer would want to buy RDGL: Bayer even bought a company to help in their mission to kill tumors and the new new company still can't do it without damaging the surrounding tissue. The are shooting for an acceptable amount of damage!
By trying to find just the right strength that will kill a tumor without causing damage to the surrounding tissue. But they are on the wrong track because different tumors need different strengths of radiation to kill them. Plus what is acceptable damage? I would say only Zero damage is acceptable.
Maybe they should buy RDGL. Here is your proof: explains Dr. Alan Cuthbertson, Head of Thorium Research at Bayer in Oslo, Norway. He and his team were part of Algeta ASA, a company that was acquired by Bayer in 2013. These specialists in the use of alpha particle-emittting radionuclides in radiotherapy are working on a means of transporting thorium directly to the tumor where the radioisotope first accumulates and then decays, releasing the alpha particles. “The radiation then destroys cancer cells without damaging the surrounding healthy tissue too severely,” explains the Bayer chemist.
Market Data 
Markets 
AI
